NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

Butterfly Network, Inc. (BFLY) Stock Analysis

Butterfly Network, Inc. (BFLY) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

BFLY

$7.36

+$0.07 (+0.96%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BFLY with… →

BFLY Key Statistics

As of Sep 4, 2026
Trading
Open
$7.28
Previous Close
$7.29
Day's Range
7.24–7.44
52-Week Range
1.47–10.05
Volume
3.05M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.09
Valuation
Market Cap
$1.96B
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
17.48
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.29
Financials (FY)
Revenue (FY)
$97.61M+18.96%
Net Income (FY)
−$77.06M
Profit marginThe share of revenue left as profit after all costs and taxes.
−66.75%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
244.86M
1-Year Return
+381.05%
Dividend and dates
Earnings Date
October 30, 2026estimated
Avg Volume
8.33M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BFLY Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+93.68%
2025+21.79%
2024+188.89%
2023−56.10%
2022−63.23%
2021−66.20%
2020 (partial year)+99.90%

As of September 4, 2026.

BFLY Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$97.61M−$77.06M−79.0%
2024$82.06M−$72.49M−88.3%
2023$65.90M−$133.70M−202.9%
2022$73.39M−$168.72M−229.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$97.61M$45.73M−$86.42M−$77.06M−79.0%
2024$82.06M$48.83M−$74.41M−$72.49M−88.3%
2023$65.90M$16.86M−$145.61M−$133.70M−202.9%
2022$73.39M$39.46M−$193.02M−$168.72M−229.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BFLY Valuation vs Medical Devices Median

Median of 151 stocks
MetricBFLYMedical Devices medianvs median
P/S ratio17.482.985.9x the median
Profit margin−66.75%−1.69%65.1 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Butterfly Network, Inc. (BFLY) at $1.96B. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 220 employees.

The 52-week range on file runs from $1.47 to $10.05. The most recent close on file for BFLY is $7.36, dated September 4, 2026. That is +$0.07 (+0.96%) against the previous close. The latest close sits 400.68% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $97.61M. Against the prior fiscal year total of $82.06M, that is a change of +18.96%. The same year closed with a net loss of $77.06M. Profit margin runs at −66.75%. That is 65.1 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.29.

Across the 4 fiscal years on file, revenue moves from $73.39M in 2022 to $97.61M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 17.48. On price-to-sales that is 5.9 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned +381.05%. Across 5 years the annualized return works out at −10.77%. Beta against the wider market is reported at 2.09. Annualized volatility over the trailing 6 years is 98.89%.

Growth & Income

No dividend is on file for BFLY.

So far in 2026 the price is +93.68%. Across the complete calendar years on file, 2024 returned +188.89% and 2021 returned −66.20%. Of the 5 complete calendar years on file, 2 finished higher.

Peer Comparison

Butterfly Network, Inc. (BFLY) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Butterfly Network, Inc. BFLY $1.96B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Butterfly Network, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Butterfly Network, Inc.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Visit website →